Related Experiment Video
Updated: Jun 16, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Gene alterations in head and neck carcinomas and their role in promoting malignant behavior (Review)
Tibor Görögh1, Ulf Henning Beier
1Division of Experimental Oncology, Department of Otorhinolaryngology Head and Neck Surgery, University of Schleswig Holstein, Campus Kiel, D-24105 Kiel, Germany. gorogh@hno.uni-kiel.de
Abstract:
Head and neck squamous cell carcinoma (HNSCC) survival remains poor despite continuing efforts toward prevention, early detection, and improved treatment modalities. In part, this is thought to be due to a relative lack of molecular targeted therapeutic strategies beyond general mitosis inhibition, which sets a limit to what modern head and neck surgery can accomplish for advanced disease. The past 30 years have produced a large quantity of data, leading to a better understanding of HNSCC carcinogenesis and novel therapeutic agents, such as epidermal growth factor receptor blockers. This article reviews literature on the current understanding of molecular HNSCC carcinogenesis, and highlights the most promising therapeutic approaches.
Insights
Survival for head and neck squamous cell carcinoma (HNSCC) is poor due to limited targeted therapies. This review covers HNSCC molecular understanding and promising new treatments for better patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Head and neck squamous cell carcinoma (HNSCC) survival rates remain low despite advances in prevention, detection, and treatment.
- Current therapeutic strategies for HNSCC are limited, particularly for advanced stages, due to a lack of molecularly targeted options beyond general mitosis inhibition.
Purpose of the Study:
- To review the current understanding of the molecular mechanisms underlying head and neck squamous cell carcinoma (HNSCC) carcinogenesis.
- To highlight promising novel therapeutic agents and strategies for HNSCC.
Main Methods:
- Literature review of scientific articles and clinical studies.
- Analysis of data on HNSCC carcinogenesis and molecular targets.
- Evaluation of emerging therapeutic approaches, including targeted therapies.
Main Results:
- Significant progress has been made in understanding HNSCC molecular pathways over the past 30 years.
- Epidermal growth factor receptor (EGFR) blockers represent one class of novel therapeutic agents.
- Several other promising molecular targets and therapeutic strategies are emerging.
Conclusions:
- A deeper understanding of HNSCC molecular carcinogenesis is crucial for developing effective treatments.
- Targeted therapies offer significant potential to improve outcomes for HNSCC patients.
- Continued research into molecular mechanisms and targeted agents is essential for advancing HNSCC care.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11:28Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
Related Concept Videos
Mitogens and the Cell Cycle
Mutagenicity and Carcinogenicity
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation